Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride helped treat a 28-year-old's facial skin condition.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requires high doses of calcium and vitamin D for management.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

MK-386 lowers DHT in blood and skin but not in semen.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Loss of COL17A1 causes hair follicle stem cells to age and leads to hair loss.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

New compounds were made that are promising for prostate cancer therapy.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Most women with hirsutism in the UAE have polycystic ovary syndrome (PCOS).

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

New LSS gene variants help understand congenital hypotrichosis 14 better.

The inhibitor DPP can promote hair growth.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.